Literature DB >> 22915280

Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and their association with markers of bone metabolism in vitamin D-deficient female students.

Zahra Jamali1, Mohammad Kazemi Arababadi, Gholamreza Asadikaram.   

Abstract

Different studies have shown the regulatory effects of vitamin D(3) on the immune system and bone metabolism. Regarding the effects of vitamin D on immune cells and the importance of cytokines on bone metabolism, we assessed the association between serum levels of interleukin (IL)-6, IL-10, IL-12, IL-17 and IFN-γ cytokines and bone metabolism markers (Ca, P, PTH, ALP) in female students with vitamin D deficiency compared with control group. A total of 100 subjects with 25-hydroxy vitamin D(3) (25-(OH) D(3)) deficiency were selected as case and 100 subjects with sufficient 25-hydroxy vitamin D(3) (25-(OH) D(3)) were selected as the control group. The serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ were measured by ELISA method. Ionized Ca, PTH, P, ALP levels were also determined in all participants. The results showed a statistically significant positive correlation between the levels of ALP with IFN-γ, PTH with IL-17 and a significant negative correlation between P with IL-10 in vitamin D deficient group. The results suggest that IL-17, IFN-γ and IL-10 are important mediators of bone metabolism and vitamin D affect bone metabolism, at least in part, through immune system. In addition, not only vitamin D affect bone metabolism but also modulates immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22915280     DOI: 10.1007/s10753-012-9531-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  37 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.

Authors:  B Abrahamsen; V Bonnevie-Nielsen; E N Ebbesen; J Gram; H Beck-Nielsen
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

3.  Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis.

Authors:  P Collin-Osdoby; L Rothe; F Anderson; M Nelson; W Maloney; P Osdoby
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

Review 4.  A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency.

Authors:  Gerry K Schwalfenberg
Journal:  Mol Nutr Food Res       Date:  2010-09-07       Impact factor: 5.914

Review 5.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.

Authors:  Michael F Holick
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

Review 6.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

7.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

Authors:  C Scheidt-Nave; H Bismar; G Leidig-Bruckner; H Woitge; M J Seibel; R Ziegler; J Pfeilschifter
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Prevalence of vitamin D deficiency among healthy adolescents.

Authors:  Catherine M Gordon; Kerrin C DePeter; Henry A Feldman; Estherann Grace; S Jean Emans
Journal:  Arch Pediatr Adolesc Med       Date:  2004-06

9.  Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density.

Authors:  D M Kania; N Binkley; M Checovich; T Havighurst; M Schilling; W B Ershler
Journal:  J Am Geriatr Soc       Date:  1995-03       Impact factor: 5.562

10.  Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus.

Authors:  Kathryn E Evans; Simon W Fox
Journal:  BMC Cell Biol       Date:  2007-01-19       Impact factor: 4.241

View more
  2 in total

Review 1.  Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Ashshi; Esam Azhar
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Mechanism of Catechol-O-methyltransferase Regulating Orofacial Pain Induced by Tooth Movement.

Authors:  Yonglong Zhou; Zhiping Song; Shibiao Chen; Fen Yao; Jian Liu; Zhiqiang Ouyang; Zhengyu Liao
Journal:  Biomed Res Int       Date:  2021-10-23       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.